Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.

318.66 6.41 −1.97%
Market cap
$26.4B
P/E
26.2×
Fwd P/E
19.0×
Dividend yield
0.90%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100

Labcorp Holdings Inc. (LH) Shares outstanding

Alert me on Shares outstanding

Labcorp Holdings Inc.'s shares outstanding at the end of fiscal 2025 was $83.8M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $82.0M. Over the past ten years it has ranged from $83.8M (fiscal 2025) to $104.3M (fiscal 2016) — the current reading is the lowest in ten years. Labcorp Holdings Inc. ranks 21st of 52 Diagnostics & Research companies by shares outstanding.

Shares outstanding, annual

Embed this chart

Annual newest first

Period Shares outstanding Change
FY2025 $83.8M (0.71%)
FY2024 $84.4M (3.65%)
FY2023 $87.6M (4.37%)
FY2022 $91.6M (6.05%)
FY2021 $97.5M (0.51%)
FY2020 $98.0M (0.61%)
FY2019 $98.6M (3.90%)
FY2018 $102.6M (1.25%)
FY2017 $103.9M (0.38%)
FY2016 $104.3M 3.68%

Quarterly newest first

Period Shares outstanding Change
Jun 2026 $82.0M (1.09%)
Mar 2026 $82.9M (1.07%)
Dec 2025 $83.8M 0.12%
Sep 2025 $83.7M (0.24%)
42 more quarters

Against its own ten years

Low $83.8M High $104.3M
Ten-year median $98.0M
Current reading's percentile 9

Shares outstanding against peers

What Shares outstanding is

Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.

Reported line item

The full definition of Shares outstanding →

More on LH